Inverness Counsel’s Novartis NVS Stock Holding History

Inverness Counsel’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,292	Closed	-$233K	–	95
2016 Q3	$233K	Sell	3,292 -2,734	-45%	-$199K	0.02%	81
2016 Q2	$446K	Hold	6,026	–	–	0.03%	75
2016 Q1	$391K	Hold	6,026	–	–	0.03%	76
2015 Q4	$465K	Sell	6,026 -447	-7%	-$35.5K	0.04%	80
2015 Q3	$533K	Hold	6,473	–	–	0.05%	78
2015 Q2	$570K	Sell	6,473 -1,486	-19%	-$136K	0.04%	80
2015 Q1	$703K	Sell	7,959 -2,299	-22%	-$204K	0.05%	80
2014 Q4	$852K	Buy	10,258 +11	+0.1%	+$912	0.07%	78
2014 Q3	$864K	Hold	10,247	–	–	0.07%	78
2014 Q2	$831K	Hold	10,247	–	–	0.06%	76
2014 Q1	$781K	Hold	10,247	–	–	0.06%	78
2013 Q4	$738K	Sell	10,247 -558	-5%	-$38.8K	0.06%	82
2013 Q3	$743K	Hold	10,805	–	–	0.06%	77
2013 Q2	$685K	Buy	+10,805	New	+$703K	0.06%	74

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.8B AUM 25.03% 1-Year Est. Return

Inverness Counsel's NVS Position: Q4 2016 in Review

Inverness Counsel sold out of Novartis (NVS) in Q4 2016, closing a stake of 3,292 shares — an estimated $233K sold.

Inverness Counsel first reported a position in NVS in Q2 2013 and held it in 14 quarters. The position peaked at $864K in Q3 2014. 905 funds tracked by Wall St. Rank hold NVS as of Q4 2016.

Inverness Counsel reported no remaining Novartis position as of Q4 2016 after selling out during the quarter.
Inverness Counsel sold 3,292 Novartis shares in Q4 2016, an estimated $233K.
Inverness Counsel first reported a position in Novartis in Q2 2013 and held it in 14 quarters.
Inverness Counsel's Novartis position peaked at $864K in Q3 2014.
905 funds tracked by Wall St. Rank held Novartis as of Q4 2016.

Based on Inverness Counsel's 13F filing for Q4 2016, filed 2 Feb 2017.